WASHINGTON Nov 9 (Reuters) - The U.S. Supreme Court on Monday rejected appeals by Daiichi Sankyo Inc and Mylan Pharmaceuticals Inc seeking to stop Apotex Inc from trying to introduce a generic version of Benicar, a drug for treating hypertension.
The justices declined to review an April ruling by the U.S. Court of Appeals for the Federal Circuit in favor of Apotex.
05:35 Arkansas carries out first execution since 2005 after Supreme Court denies stay requests19
05:18 The Latest: Inmate lost consciousness quickly, witnesses say24
05:18 Arkansas Puts Ledell Lee to Death, in Its First Execution Since 200524
04:47 Arkansas Again Faces Two Legal Roadblocks Day Ahead of Execution38